People diagnosed with schizophrenia have an increased risk of developing Parkinson's disease later in life, researchers report. The reason could be due to alterations in the brain's dopamine system cause as a result of dopamine receptor antagonists or neurophysiological changes associated with schizophrenia itself. Read More
Mutations of the ABCA13 cholesterol transport protein are associated with schizophrenia-like behaviors in mouse models. Read More
Changes in fetal microglia caused as a result of maternal inflammation could contribute to the development of schizophrenia, autism, and other psychiatric or developmental disorders. Read More
Using human-induced pluripotent stem cells, researchers have identified a gene signaling pathway linked to a higher risk of developing schizophrenia. Read More
Low-intensity exercise during adolescence reduces behavioral symptoms associated with schizophrenia in mouse models. Read More
Inducing hallucinations using visual stimuli in a lab setting enables more objective and reliable testing. Read More
Schizophrenia may, in part, be caused by immune system dysfunction, a new study reports. Treatment with Methotrexate, a drug commonly prescribed for autoimmune disorders like R.A, produced positive effects against some prominent schizophrenia symptoms. Read More
Study adds to the growing evidence Bartonella infection is associated with neuropsychological symptoms in addition to dermatological symptoms. Read More
White matter connectivity does not directly induce psychosis, but may affect symptoms of psychosis through its effect on the consciousness threshold. Read More
Behavioral changes in those with T.gondii infection could be linked to lower levels of norepinephrine. Norepinephrine also controls inflammation. Both neuroinflammation and norepinephrine are associated with a range of psychiatric disorders including schizophrenia and ADHD. Read More
Hallucinations and delusions share a common neurobiological mechanism while simultaneously depending on symptom-specific pathways. Read More
STAT3 plays a crucial role in the serotonergic system as a molecular mediator for controlling emotional reactivity. The findings establish a link between the immune system, serotonergic transmission, and affective disorders such as depression. Read More